21 Feb 2017
N+1 Singer - Abzena - Contract bookings strong; US costs higher than expected
Abzena’s trading and business update highlights strong contract bookings and expected FY 2017 revenue in line with the Board’s previous expectations, whilst US expenditure is expected to be higher than previously anticipated as a result of increased investment in capacity expansion. Importantly, cash at year-end is anticipated to be in line with previous expectations. The Abzena inside portfolio continues to expand, with a further programme having entered clinical trials bringing the total numbe ....
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
N+1 Singer - Abzena - Contract bookings strong; US costs higher than expected
Abzena (ABZA:LON) | 0 0 (-0.9%) | Mkt Cap: 54.0m
- Published:
21 Feb 2017 -
Author:
Dr Jens Lindqvist -
Pages:
4
Abzena’s trading and business update highlights strong contract bookings and expected FY 2017 revenue in line with the Board’s previous expectations, whilst US expenditure is expected to be higher than previously anticipated as a result of increased investment in capacity expansion. Importantly, cash at year-end is anticipated to be in line with previous expectations. The Abzena inside portfolio continues to expand, with a further programme having entered clinical trials bringing the total numbe ....